Health-related quality of life (HRQL) in patients with advanced cutaneous squamous cell carcinoma (CSCC) treated with cemiplimab: Post hoc exploratory analyses of a phase II clinical trial.

被引:0
作者
Migden, Michael Robert
Rischin, Danny
Sasane, Medha
Mastey, Vera
Pavlick, Anna
Schmults, Chrysalyne D.
Chen, Zhen
Guminski, Alexander David
Hauschild, Axel
Bury, Denise
Chang, Anne Lynn S.
Rabinowits, Guilherme
Ibrahim, Sherrif F.
Lowy, Israel
Fury, Matthew G.
Li, Siyu
Chen, Chieh-I
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA
[3] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[4] Sanofi, Bridgewater, NJ USA
[5] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[6] NYU, Langone Med Ctr, Dept Med Oncol, New York, NY USA
[7] Harvard Med Sch, Dept Dermatol, Brigham & Womens Hosp, Boston, MA 02115 USA
[8] Royal North Shore Hosp, Dept Med Oncol, St Leonards, NSW, Australia
[9] Univ Hosp UKSH, Dept Dermatol, Kiel, Germany
[10] Sanofi, Cambridge, MA USA
[11] Stanford Univ, Sch Med, Dept Dermatol, Redwood City, CA USA
[12] Baptist Hlth South Florida, Miami Canc Inst, Dept Hematol Oncol, Miami, FL USA
[13] Rochester Med Ctr, Dept Dermatol, Rochester, NY USA
[14] Regeneron Pharmaceut Inc, Basking Ridge, NJ USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
10033
引用
收藏
页数:2
相关论文
empty
未找到相关数据